Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community [NA]
A clinical trial is evaluating the feasibility of computer-based cognitive training for individuals with Multiple Sclerosis living in the co…
-
CLINICAL_TRIALS other · 2025-02-21Clinical Trial Update: Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients [NA]
A clinical trial evaluating the impact of virtual reality physiotherapy in patients with Multiple Sclerosis; recruitment is ongoing at the E…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Effect of High Tone Power Therapy on Bladder Disturbance [NA]
A clinical trial update shows a study evaluating High Tone Power Therapy for bladder disturbance in individuals with Multiple Sclerosis, wit…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis [Phase 1]
Phase 1 trial assessing safety and feasibility of autologous EBV-specific cytotoxic T lymphocytes in patients with a first clinical episode …
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Cerebellar RTMS in Patients with Multiple Sclerosis [NA]
A clinical trial investigating cerebellar repetitive transcranial magnetic stimulation in patients with Multiple Sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-19FDA Approved: FINGOLIMOD — Supplemental Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's supplemental application for fingolimod hydrochloride (generic fingolimod), expanding access for tre…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Cognitive Reserve-building Activities in Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial investigating cognitive reserve-building activities for people with multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
The IConquerMS study, a patient-powered research network for multiple sclerosis, is currently recruiting participants.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study [NA]
This record reports the completion of a clinical trial evaluating a spinal cord neuromodulation therapy (SCONE) by SpineX for neurogenic bla…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Investigation of the Effects of Pilates Training Combined with Whole Body Vibration on Balance and Mobility in Individuals with Multiple Sclerosis [NA]
A completed clinical trial evaluated the effects of Pilates training combined with whole body vibration on balance and mobility in individua…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Spinal Cord Monitoring in Multiple Sclerosis
A clinical trial is ongoing to assess spinal cord monitoring in individuals with Multiple Sclerosis, with recruitment currently in progress.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Unraveling Active Ingredients of Neurorehabilitation: Investigating Cortical Activity During Task-oriented Exercises
A clinical trial is exploring cortical activity during task-oriented neurorehabilitation exercises in individuals with Multiple Sclerosis, w…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Serum Neurofilament Light in Multiple Sclerosis
This entry notes an ongoing study of serum neurofilament light in multiple sclerosis, currently active but not recruiting.
-
EMA approval · 2025-02-13EMA Authorised: Dimethyl fumarate Neuraxpharm (dimethyl fumarate) — Neuraxpharm Pharmaceuticals S.L.
The European Medicines Agency authorised Dimethyl fumarate from Neuraxpharm Pharmaceuticals S.L. for the treatment of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment. [NA]
The document reports the completion of a clinical trial evaluating Holter of Movement in patients with Multiple Sclerosis under controlled c…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Improving Learning and Memory in Portuguese Patients With Multiple Sclerosis [NA]
A clinical trial in Portugal is recruiting to study improvements in learning and memory in people with Multiple Sclerosis. The study is spon…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment. [NA]
A clinical trial registry entry for a study evaluating movement monitoring in people with multiple sclerosis in an uncontrolled environment;…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis [NA]
This completed clinical trial from The Cleveland Clinic evaluated the therapeutic effects of forced aerobic exercise in individuals with mul…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: ACTH in Progressive Forms of MS [Phase 2]
A Phase 2 trial evaluating adrenocorticotropic hormone (ACTH) for progressive forms of multiple sclerosis has been terminated; results have …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation [NA]
An ongoing study at Universita di Verona compares isolated versus combined high-tech rehabilitation focusing on cognitive and motor function…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Disability Level and Trunk Control in Individuals With Multiple Sclerosis
A completed clinical trial studying disability level and trunk control in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Short-term B-cell Depletion in Relapsing Multiple Sclerosis [Phase 4]
This clinical trial update reports results from a Phase 4 study examining short-term B-cell depletion in relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Home Based Tele-exercise for People With Chronic Neurological Impairments [NA]
A clinical trial (NCT04564495) evaluating home-based tele-exercise for people with chronic neurological impairments is currently active but …
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Covid-19 Vaccine Immune Response in Multiple Sclerosis
Clinical trial evaluating immune response to a Covid-19 vaccine in people with Multiple Sclerosis; currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia [Phase 4]
Phase 4 study of suvorexant in patients with Multiple Sclerosis–related fatigue and insomnia has completed, with results posted.